Newell Evan W, Lin Wenyu
Singapore Immunology Network (SIgN), Agency for Science Technology and Research (A-STAR), Singapore, 138648, Republic of Singapore,
Curr Top Microbiol Immunol. 2014;377:61-84. doi: 10.1007/82_2013_354.
Antigen-specific T cells are critical initiators and orchestrators of the adaptive immune response. Categorizing antigen-specific T cell subsets is not a simple task given the diversity of these cells and the large number of parameters that can be considered. Here, we focus on human CD8(+) T cells and discuss the utility of high-dimensional mass cytometric analysis techniques for the concurrent identification and characterization of antigen-specific T cells involved in immunological homeostasis and disease. We first provide an overview of previously identified T cell subsets. We then discuss the segregation of antigen-specific T cells based on protein expression through surface and/or intracellular staining, on functional capacity through measurement expression of cytokines or other inducible markers, and on the antigen-specificity of the cell assessed using peptide-major histocompatibility complex multimers. High-dimensional mass cytometry enables a deeper and more integrated view of all three aspects of antigen-specific T cell diversity than do traditional techniques. Use of mass cytometry for precise measurement of the status of antigen-specific immune responses should result in better prediction of vaccine efficacy and disease outcomes.
抗原特异性T细胞是适应性免疫反应的关键启动者和协调者。鉴于这些细胞的多样性以及可考虑的大量参数,对抗原特异性T细胞亚群进行分类并非易事。在此,我们聚焦于人类CD8(+) T细胞,并讨论高维质谱流式细胞分析技术在同时鉴定和表征参与免疫稳态及疾病的抗原特异性T细胞方面的效用。我们首先概述先前已鉴定的T细胞亚群。接着,我们讨论基于蛋白质表达通过表面和/或细胞内染色来区分抗原特异性T细胞,基于细胞因子或其他诱导性标志物的测量表达来区分其功能能力,以及基于使用肽-主要组织相容性复合体多聚体评估的细胞抗原特异性来区分。与传统技术相比,高维质谱流式细胞术能够更深入、更全面地了解抗原特异性T细胞多样性的所有三个方面。使用质谱流式细胞术精确测量抗原特异性免疫反应的状态应能更好地预测疫苗效力和疾病结局。